Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH

Cancer Genetics and Cytogenetics

Volumn 168, Issue 2, 2006, Pages 133-145

  Shali, Wei ^a   Hélias, Catherine ^a   Fohrer, Cécile ^a   Struski, Stéphanie ^a   Gervais, Carine ^a   Falkenrodt, Annie ^a   Leymarie, Vincent ^a   Lioure, Bruno ^a   Raby, Pascale ^b   Herbrecht, Raoul ^a   Lessard, Michel ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Pasteur Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTIMETABOLITE; BUSULFAN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; EPIPODOPHYLLOTOXIN DERIVATIVE; EPIRUBICIN; HYDROXYUREA; IDARUBICIN; IFOSFAMIDE; MELPHALAN; MITOXANTRONE; NITROSOUREA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHROMOSOME 12P; CHROMOSOME 17Q; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE DELETION; GENE FREQUENCY; GENE TRANSLOCATION; GENETIC LINKAGE; HODGKIN DISEASE; HUMAN; KIDNEY CARCINOMA; LEUKEMIA; LUNG CARCINOMA; MALE; MOLECULAR EVOLUTION; MONOCLONAL IMMUNOGLOBULINEMIA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OVARY CARCINOMA; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GENE AMPLIFICATION; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC;

EID: 33745754798     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.02.006     Document Type: Article

References (34)

1. Mitelman F., Brandt L., and Nilsson P.G. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 52 (1978) 1229-1237
2. Brandt L., Nilsson P.G., and Mitelman F. Non-industrial exposure to benzene as leukaemogenic risk factor. Lancet 2 (1977) 1074
3. Kyle R.A., Pierre R.V., and Bayrd E.D. Multiple myeloma and acute myelomonocytic leukemia: report of four cases possibly related to melphalan. N Engl J Med 283 (1970) 1121-1125
4. Cadman E.C., Capizzi R.L., and Bertino J.R. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases. Cancer 40 (1977) 1280-1296
5. Rowley J.D., Golomb H.M., and Vardiman J. Acute leukaemia after treatment of lymphoma. N Engl Med 297 (1977) 1013
6. Streuli R.A., Testa J.R., Vardiman J.W., Mintz U., Golomb H.M., and Rowley J.D. Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies. Blood 55 (1980) 636-644
7. Speicher M.R., Gwyn Ballard S., and Ward D.C. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12 (1996) 368-375
8. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., and Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103 (1985) 620-625
9. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organisation classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon
10. Weber L.M., and Garson O.M. Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet Cytogenet 8 (1983) 123-132
11. Mitelman F. An international system for human cytogenetic nomenclature. Guidelines for cancer cytogenetics (supplement to an International system for human cytogenetic nomenclature) (1995), S. Karger, Basel, Switzerland
12. Lee C., Gisselsson D., Jin C., Nordgren A., Ferguson D.O., Blennow E., Fletcher J.A., and Morton C. Limitations of chromosome classification by multicolor karyotyping. Am J Hum Genet 68 (2001) 1043-1047
13. Pedersen-Bjergaard J., Timshel S., Andersen M.K., Thöger Andersen A.S., and Philip P. Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases. Genes Chromosomes Cancer 23 (1998) 337-349
14. Lessard M., Herry A., Berthou C., Leglise M.C., Abgrall J.F., Morice P., and Flandrin G. FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes. Leukemia Res 22 (1998) 303-312
15. Pedersen-Bjergaard J., and Philip P. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukaemia following therapy with cytostatic agents targeting at DNA-topoisomerase. Blood 17 (1991) 1147-1148
16. Bloomfield C.D., Archer K.J., Mrozek K., Lillington D.M., Kaneko Y., Head D.R., Dal Cin P., and Raimondi S.C. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33 (2002) 362-378
17. Rowley J.D., Reshmi S., Sobulo O., Musvee T., Anastasi J., Raimondi S., Schneider N.R., Barredo J.C., Cantu E.S., Schlegelberger B., Behm F., Doggett N.A., Borrow J., and Zeleznik-Le N. All patients with the t(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 90 (1997) 535-541
18. Block A.M.W., Caroll A.J., Hajemeijer A., Michaux L., van Lom K., Olney H.J., and Baer M.R. Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33 (2002) 401-412
19. Gervais C., Mauvieux L., Perrusson N., Helias C., Struski S., Leymarie V., Lioure B., and Lessard M. A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia. Leukemia 19 (2005) 145-148
20. Mrozek K., Heinonen K., Theil K., and Bloomfield C. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overexpression of 21q, 11q, and 22q. Genes Chromosomes Cancer 34 (2002) 137-153
21. Cournoyer D., Noel P., Schmidt M.A., and Dewald G.W. Trisomy 9 in hematologic disorders: possible association with primary thrombocytosis. Cancer Genet Cytogenet 27 (1987) 73-78
22. Groupe Français de Cytogenetique Hematologique. Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Cancer Genet Cytogenet 32 (1988) 157-168
23. Swolin B., Weinfeld A., and Westin J. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 72 (1988) 386-395
24. Bacher U., Haferlach T., and Schoch C. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders. Cancer Genet Cytogenet 160 (2005) 179-183
25. Andersen M.K., and Pedersen-Bjergaard J. Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere. Leukemia 14 (2000) 105-111
26. Sterkers Y., Preudhomme C., Lai J.L., Demory J.L., Caulier M.T., Wattel E., Bordessoule D., Bauters F., and Fenaux P. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood 91 (1998) 616-622
27. Lai J.L., Preudhomme C., Zandecki M., Flactif M., Vanrumbeke M., Lepelley P., Wattel E., and Fenaux P. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations. Leukemia 9 (1995) 370-381
28. Laï J.L., Zandecki M., Fenaux P., Le Baron F., Bauters F., Cosson A., and Deminatti M. Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemias. Cancer Genet Cytogenet 46 (1990) 173-183
29. Andersen M.K., Christiansen D.H., Kirchhoff M., and Pedersen-Bjergaard J. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents. Genes Chromosomes Cancer 31 (2001) 33-41
30. Van Limbergen H., Poppe B., Michaux L., Herens C., Brown J., Noens L., Berneman Z., De Bock R., De Paepe A., and Speleman F. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes Chromosomes Cancer 33 (2002) 60-72
31. Weinfeld A., Swolin B., and Westin J. Acute leukaemia after hydroxyurea therapy in polycythemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications. Eur J Haematol 52 (1994) 134-139
32. Barbui T. The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?. Semin Hematol 41 (2004) 15-17
33. Groupe Français de Cytogénétique Hématologique. Chromosome analysis of 63 cases of secondary nonlymphoid blood disorders: a cooperative study. Cancer Genetics Cytogenetics 12 (1984) 95-104
34. Barouk-Simonet E., Soenen-Cornu V., Roumier C., Cosson A., Laï J.-L., Fenaux P., and Preudhomme C. Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes: a report on 28 cases. Cancer Genet Cytogenet 157 (2005) 118-126